Tuesday, December 22, 2015What I Learned In 2015: Richard Wolpert, HelloTech
As is the tradition at socaltech, over the holidays we publish contributions from some of the movers and shakers in the community, with their reflections on the past year and their thoughts on the upcoming year. We'll be publishing these between now and the new year. Our first for this year is from Richard Wolpert, founder of HelloTech (www.hellotech.com), an in-home, technology and IT support service. Wolpert is also a longtime angel investor in Southern California's technology industry, help (More info...)
posted on Tuesday, December 22, 2015(Full story)
Ingram Micro Wraps Up Two AcquisitionsIrvine-based Ingram Micro, the technology product distribution giant, has wrapped up two acquisition, including the acquisition of Latin American value added distributor Grupo ACAO, as well as the Odin Service Automation platform from Parallels Holdings Ltd. Both acquisition had recently been announced. Grupo ACAO is based in Sao Paulo, Brazil, and is a provider of value added IT products. Parallels' Odin Service Automation platform is used for cloud services management. Financial terms of the t (More info...)
posted on Tuesday, December 22, 2015(Full story)
eFFECTOR Therapeutics Picks Up $40M For Cancer TreatmentsSan Diego-based eFFECTOR Therapeutics, a biopharmaceuticals startup focused on treatment of cancer, announced this morning that it has raised $40M in a Series B funding. The funding was led by Altitude Life Science Ventures and also included AbbVie Biotech Ventures, BioMed Ventures, Abingworth, Novartis Venture Fund, SR One, The Column Group, US Venture Partners, Astellas Ventures, Osage University Partners and Mission Bay Capital.
eFFECTOR is led by Steve Worland, and is targeting treatment (More info...)
posted on Tuesday, December 22, 2015 (More)(Full story)
AVACEN Medical Hires Investment Banker, Looks For BuyerSan Diego-based AVACEN Medical, a developer of medical devices for treating fibromyalgia, said this morning that it has retained investment banker Objective Capital Partners, and is looking to sell the company. AVACEN Medical is led by Thomas G. Muehlbauer. The company said the attempt to sell the company came after the company decided it was in the "best interest of its shareholders" to offer itself up as an acquisition target.
posted on Tuesday, December 22, 2015(Full story)